What is it about?

BACKGROUND: Metabolic and inflammatory conditions may lead to neurological disorders. Neuromyelitis optica spectrum disorders (NMOSDs) refer to a rare group of demyelinating diseases of the central nervous system which essentially involve the optic nerves and spinal cord. METHODS: We report a case of biotinidase deficiency (BD) initially misdiagnosed as NMOSD in a pediatric patient. RESULTS: An 8-year-old girl was initially diagnosed with NMOSD on the basis of optic neuritis (ON) associated with three episodes of longitudinally extensive transverse myelitis (LETM). Intravenous high-dose corticosteroids were effective during the first two episodes of LETM. The third acute episode which resulted in tetraplegia, respiratory distress, and blindness was refractory to corticosteroids, plasmapheresis, and rituximab. The unusual clinical course and persistent high levels of plasma and cerebrospinal fluid (CSF) lactate led to additional metabolic investigations being performed. Acylcarnitine profile revealed increased C5-OH acylcarnitine suggestive of BD. Diagnosis was confirmed by direct assessment of plasma enzyme activity (quantified as 5% of the control value). Genetic analysis revealed two mutations, c.643C>T (p.L215F) and c.1612C>T (p.R538C), in the BTD gene (3p25). Dramatic clinical improvement occurred after long-term oral biotin treatment. CONCLUSION: BD is a treatable condition that may closely mimic the neurological findings of LETM and NMOSD. KEYWORDS: Devic’s disease; Neuromyelitis optica; biotinidase deficiency; children; myelitis; optic neuritis

Featured Image

Why is it important?

Biotinidase deficiency is a treatable diseases that may closely mimic the neurological findings of longitudinally extensive transverse myelitis and neuromyelitis optica spectrum disorders as defined in " Revised diagnostic criteria for neuromyelitis optica. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Neurology 2006; 66(10): 1485–1489".

Perspectives

In patients with criteria for NMOSD if there is an elevated serum lactate levels, consideration of biotinidase deficiency and genetic evaluation should be prompt.

Dr Barbara GIRARD
Nancy Childrens' Hospital

Read the Original

This page is a summary of: Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease, Multiple Sclerosis Journal, July 2016, SAGE Publications,
DOI: 10.1177/1352458516646087.
You can read the full text:

Read

Contributors

The following have contributed to this page